Ozempic
- Product NDC
- 70518-2143
- 11-digit product format
- 705182143
- Labeler code
- 70518
- Product ID
- 70518-2143_c68a9472-9ccd-d006-e053-2a95a90a647b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- semaglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- REMEDYREPACK INC.
- Application
- NDA209637
- Marketing category
- NDA
- Marketing start
- 2019-06-11
- Marketing end
- 0000-00-00
- Substance
- SEMAGLUTIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2143-0 | 70518214300 | 2 SYRINGE, PLASTIC in 1 CARTON (70518-2143-0) > 1.5 mL in 1 SYRINGE, PLASTIC | 2019-06-11 | 0000-00-00 | No | No | Current |